Currently, the role of IKZF1/3 degraders, especially cellular modulator of immune recognition (CELMoD), is being explored beyond MM, particularly in B-cell lymphomas and some T-cell lymphomas. This evidence concerns the gene IKZF1 and T-cell non-Hodgkin lymphoma.